Please login to the form below

Not currently logged in
Email:
Password:

Former FDA head to join J&J

Mark McClellan elected to pharma company’s board

Mark McClellan Johnson and JohnsonJohnson & Johnson (J&J) has elected the former head of the US Food and Drug Administration (FDA) Dr Mark McClellan to its board.

Dr McClellan was FDA commissioner from 2002 to 2004 leading the government body's activities in regulating the pharma and food industries in the US. During this time, he implemented the Critical Path Initiative series of reforms to modernise pharma manufacturing.

He has additional senior experience in government, serving as the administrator of the Centers for Medicare & Medicaid Services for the US Department of Health and Human Services from 2004 to 2006. Prior to this he spent two decades in the public and academic research sectors.

He also served as a member of the President's Council of Economic Advisers and senior director for health care policy at the White House during the administration of George W Bush.

Alex Gorsky, chairman and CEO of J&J, commented on Dr McClellan's move from the public sector to a private healthcare firm.

“Dr McClellan has a distinguished record in the public sector as well as a deep understanding and vision for the future of health care,” he said. “Mark shares our aspiration to help people live longer, healthier and happier lives and personally is committed to improving health care across the globe.”

Unsurprisingly for someone with his background, Dr McClellan will serve on both J&J's regulatory, compliance and government affairs committee and its science, technology and sustainability committee.

17th October 2013

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...
BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....

Infographics